Publication:
Computer-Based Drug-Utilization Review — Risk, Benefit, or Boondoggle?

Thumbnail Image

Date

1995

Journal Title

Journal ISSN

Volume Title

Publisher

New England Journal of Medicine (NEJM/MMS)
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Soumerai, Stephen B., and Helene L. Lipton. 1995. “Computer-Based Drug-Utilization Review — Risk, Benefit, or Boondoggle?” New England Journal of Medicine 332 (24) (June 15): 1641–1645. doi:10.1056/nejm199506153322411.

Research Data

Abstract

On October 28, 1990, with little debate, Congress passed the Omnibus Budget Reconciliation Act, requiring the states to provide claims-based drug-utilization review to approximately 34 million Medicaid enrollees. The provisions of the program were borrowed from the ill-fated Medicare Catastrophic Coverage Act of 1988, repealed in 1990; the stated goals were to reduce potentially inappropriate prescribing and dispensing of medications, enhance the counseling of patients, and reduce growth in expenditures for drugs. Drug-utilization review is a structured, ongoing program that interprets patterns of drug use in relation to predetermined criteria and attempts to prevent or minimize inappropriate prescribing.

Description

Other Available Sources

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories